1Suppliers
1Customers
2Debt Items
4Related Chains

Alkermes plc Suppliers

TickerNameConfidenceEvidence
AMRX Amneal Pharmaceuticals, Inc. 85% Reciprocal relationship from AMRX graph: Reciprocal relationship from ALKS graph: Reciprocal relationship from AMRX graph: Reciprocal relationship from ALKS graph: Reciprocal relationship from AMRX g…

Alkermes plc Customers

TickerNameConfidenceEvidence
SPECIALTY-PHARMACIES SPECIALTY-PHARMACIES 90% Product sales, net are recognized when the customer obtains control of the product, which is when the product has been received by the customer. During the three months ended March 31, 2026 and 2025,…

Alkermes plc Debt Obligations

InstrumentDescriptionConfidenceEvidence
ALKS-DEBT Debt stack $1.6B 90% Market cache reports total debt of $1.6B.
ALKS-DEBT-7681 Xbrl Convertible 90% xbrl convertible detail from xbrl 2013-03-31.

Alkermes plc Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Alkermes plc.

Alkermes plc Ownership

HolderNameConfidenceEvidence
ALKS-OWNER-BLACKROCK-INC BlackRock, Inc. 90% 13F overlay lists BlackRock, Inc. as top holder; 390 tracked holders.

Alkermes plc Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
RDY Dr. Reddy's Laboratories Limited 100.00 2
CHRS Coherus Oncology, Inc. 50.00 2
SPRY ARS Pharmaceuticals, Inc. 50.00 2
AMRX Amneal Pharmaceuticals, Inc. 42.84 1 ['supplier']